OUTLOOK THERAPEUTICS INC (OTLK)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 119.04M
P/E Ratio
0.00
Revenue (TTM)
$ 1.51M
Volume
0
52W High
$ 8.32
52W Low
$ 0.87
Dividend Yield
0.00%
Beta
0.27
Technicals
50-Day MA
2.0139
200-Day MA
2.0938
52 Week High
8.32
52 Week Low
0.87
About OTLK
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
Employees
23
Headquarters
Iselin, NJ
CEO
Mr. Lawrence A. Kenyon CPA
Latest News
Outlook Therapeutics: Why The Odds Point To A Favorable FDA Decision - Seeking Alpha
2 days ago • Google News